A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM)
-
Published:2024-01
Issue:
Volume:196
Page:113455
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Dayimu AlimuORCID, Gupta Avinash, Matin Rubeta N., Nobes JennyORCID, Board Ruth, Payne Miranda, Rao Ankit, Fusi Alberto, Danson Sarah, Eccles Bryony, Carser Judith, Brown Ciara O’Hanlon, Steven Neil, Bhattacharyya Madhumita, Brown Ewan, Gonzalez Michael, Highley Martin, Pickering Lisa, Kumar Satish, Waterston AshitaORCID, Burghel GeorgeORCID, Demain Leigh, Baker Eleanor, Wulff JeromeORCID, Qian Wendi, Twelves SophieORCID, Middleton MarkORCID, Corrie PippaORCID
Subject
Cancer Research,Oncology
|
|